BACKGROUND: Although elderly patients have been included in published series of catheter ablation for atrial fibrillation (AF), clinical benefit and safety remain still less defined in this population. A retrospective analysis of the results of catheter ablation for AF in a large volume center focused on comparison of elderly patients with the rest of the patient cohort was conducted in this study. METHODS: Consecutive patients who underwent catheter ablation for AF between January 2001 and December 2016 were analysed. A total population of 3197 patients was dichotomized by the age of 70 years (394 elderly vs. 2803 younger subjects). Patients were followed in terms of arrhythmia status and survival for a median period of 18 vs. 21 and 35 vs. 57 months, respectively. RESULTS: Elderly patients were more frequently females (49% vs. 29%, P < 0.0001), had a history of hypertension (79% vs. 57%, P < 0.0001), diabetes (16% vs. 11%, P < 0.01), stroke (9% vs. 6%, P < 0.01), coronary/peripheral artery disease (14% vs. 8%, P < 0.0001), and CHA2DS2-VASc score (3.1 ± 1.3 vs. 1.5 ± 1.2 s, P < 0.0001). Major complications were more frequent in elderly (5.3% vs. 3.2%, P = 0.03); however, this difference was driven by vascular complications (3.6% vs. 1.9%, P = 0.04). There were comparable rates of cerebrovascular (0.3 vs. 0.3%) or nonvascular complications (1.8 vs. 1.2%). Good arrhythmia control was inferior in elderly patients as compared with the rest of the cohort, both without and with antiarrhythmic drugs: 44.2% vs. 58.2% (P < 0.0001) and 78.2 vs. 83.2% (P < 0.01), respectively. Poor arrhythmia control was associated with relative risk of all-cause mortality of 2.7 (95% CI: 1.1-6.4) in elderly patients and 1.4 (95% CI: 0.9-2.0) in younger subjects. CONCLUSIONS: Catheter ablation for AF in elderly patients is safe although somewhat less effective. Good arrhythmia control is associated with better survival, especially in elderly patients.

Department of Cardiology Institute for Clinical and Experimental Medicine Videnska 1958 9 14021 Prague Czech Republic

See more in PubMed

Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–2962. PubMed

Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation: Analysis and implications. Arch Intern Med. 1995;155:469–473. PubMed

Go A, Hylek E, Phillips K, et al. Prevalence of diagnosed atrial fibrillation in adults. JAMA. 2001;285:2370–2375. PubMed

Stewart S, Hart CL, Hole DJ, McMurray JJV. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113:359–364. PubMed

Kannel W, Abbott R, Savage D, Mc Namara P. Epidemiologic features of chronic atrial fibrillation. N Engl J Med. 1982;306:1018–1022. PubMed

Sramko M, Peichl P, Wichterle D, et al. A novel biomarker-based approach for the detection of asymptomatic brain injury during catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25:349–354. PubMed

Aldhoon B, Wichterle D, Peichl P, et al. Complications of catheter ablation for atrial fibrillation in a high-volume centre with the use of intracardiac echocardiography. Europace. 2013;15:24–32. PubMed

Bhargava M, Marrouche N, Martin D, et al. Impact of age on the outcome of pulmonary vein isolation for atrial fibrillation using circular mapping technique and cooled-tip ablation catheter: a retrospective analysis. J Cardiovasc Electrophysiol. 2004;15:8–13. PubMed

Zado E, Callans DJ, Riley M, et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. J Cardiovasc Electrophysiol. 2008;19:621–626. PubMed

Corrado A, Patel D, Riedlbauchova L, et al. Efficacy, safety and outcome of atrial fibrillation ablation in septuagenarians. J Cardiovasc Electrophysiol. 2008;19:807–811. PubMed

Kusumoto F, Prussak K, Wiesinger M, et al. Radiofrequency catheter ablation of atrial fibrillation in older patients: outcomes and complications. J Interv Card Electrophysiol. 2009;25:31–35. PubMed

Nademanee K, Amnueypol M, Lee F, et al. Benefits and risks of catheter ablation in elderly patients with atrial fibrillation. Heart Rhythm. 2015;12:44–51. PubMed

Bunch TJ, Weiss JP, Crandall BG, et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians. Pacing Clin Electrophysiol. 2010;33:146–152. PubMed

Tan HW, Wang XH, Shi HF, et al. Efficacy, safety and outcome of catheter ablation for atrial fibrillation in octogenarians. Int J Cardiol. 2010;145:147–148. PubMed

Santangeli P, Biase L, Mohanty P, et al. Catheter ablation of atrial brillation in octogenarians: safety and outcomes. J Cardiovasc Electrophysiol. 2012;23:687–693. PubMed

Blandino A, Toso E, Scaglione M, et al. Long-term efficacy and safety of two different rhythm control strategies in elderly patients with symptomatic persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24:731–738. PubMed

Ghanbari H, Baser K, Jongnarangsin, et al. Mortality and cerebrovascular events after radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm. 2014;11:1503–1511. PubMed

Friberg L, Tabrizi F, Englund A. Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. Eur Heart J. 2016;37:2478–2487. PubMed

Metzner I, Wissner E, Tilz RR, et al. Ablation of atrial fibrillation in patients ≥ 75 years: long-term clinical outcome and safety. Europace. 2016;18:543–549. PubMed

Moser JM, Willems S, Andresen D, et al. Complication rates of catheter ablation of atrial fibrillation in patients aged ≥ 75 years versus < 75 years-Results from the German Ablation Registry. J Cardiovasc Electrophysiol. 2017;28:258–265. PubMed

Spragg DD, Dalal D, Cheema A, et al. Complications of catheter ablation for atrial fibrillation: incidence and predictors. J Cardiovasc Electrophysiol. 2008;19:627–631. PubMed